APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coagulation Factor IX

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Coagulation Factor IX Market Analysis and Forecast 2026-2032

20 December 2025196 pages

Choose your research edition.

Industry ResearchCoagulation Factor IX Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Coagulation Factor IX Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Coagulation Factor IX Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coagulation Factor IX Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Coagulation Factor IX Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Coagulation Factor IX market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Coagulation Factor IX is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Coagulation Factor IX is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Coagulation Factor IX is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Coagulation Factor IX is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Coagulation Factor IX include Takeda, Novo Nordisk, Pfizer, Baxter, Sanquin, Grifols, CSL Behring, Bioverativ and Aptevo, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Coagulation Factor IX, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Coagulation Factor IX, also provides the sales of main regions and countries. Of the upcoming market potential for Coagulation Factor IX, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Coagulation Factor IX sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Coagulation Factor IX market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Coagulation Factor IX sales, projected growth trends, production technology, application and end-user industry.

Coagulation Factor IX Segment by Company

Takeda

Novo Nordisk

Pfizer

Baxter

Sanquin

Grifols

CSL Behring

Bioverativ

Aptevo

Coagulation Factor IX Segment by Type

Coagulation Factor IX (Plasma Derived)

Coagulation Factor IX (Recombinant)

Coagulation Factor IX Segment by Application

Adult

Kids

Coagulation Factor IX Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coagulation Factor IX market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coagulation Factor IX and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coagulation Factor IX.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Coagulation Factor IX in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Coagulation Factor IX manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Coagulation Factor IX sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Coagulation Factor IX Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Coagulation Factor IX (Plasma Derived) Major Manufacturers Table 3. Coagulation Factor IX (Recombinant) Major Manufacturers Table 4. Global Coagulation Factor IX Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Adult Major Manufacturers Table 6. Kids Major Manufacturers Table 7. Coagulation Factor IX Industry Trends Table 8. Coagulation Factor IX Industry Drivers Table 9. Coagulation Factor IX Industry Opportunities and Challenges Table 10. Coagulation Factor IX Industry Restraints Table 11. Global Coagulation Factor IX Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Coagulation Factor IX Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Coagulation Factor IX Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Coagulation Factor IX Revenue Market Share by Region (2021-2026) Table 15. Global Coagulation Factor IX Revenue Market Share by Region (2027-2032) Table 16. Global Coagulation Factor IX Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 17. Global Coagulation Factor IX Sales by Region (2021-2026) & (W Units) Table 18. Global Coagulation Factor IX Sales by Region (2027-2032) & (W Units) Table 19. Global Coagulation Factor IX Sales Market Share by Region (2021-2026) Table 20. Global Coagulation Factor IX Sales Market Share by Region (2027-2032) Table 21. Global Coagulation Factor IX Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Coagulation Factor IX Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Coagulation Factor IX Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Coagulation Factor IX Sales Market Share by Manufacturers (2021-2026) Table 25. Global Coagulation Factor IX Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Coagulation Factor IX Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Coagulation Factor IX Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Coagulation Factor IX Manufacturers, Product Type & Application Table 29. Global Coagulation Factor IX Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Coagulation Factor IX by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Coagulation Factor IX Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Coagulation Factor IX Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Coagulation Factor IX Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Coagulation Factor IX Revenue Market Share by Type (2021-2026) Table 36. Global Coagulation Factor IX Revenue Market Share by Type (2027-2032) Table 37. Global Coagulation Factor IX Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 38. Global Coagulation Factor IX Sales by Type (2021-2026) & (W Units) Table 39. Global Coagulation Factor IX Sales by Type (2027-2032) & (W Units) Table 40. Global Coagulation Factor IX Sales Market Share by Type (2021-2026) Table 41. Global Coagulation Factor IX Sales Market Share by Type (2027-2032) Table 42. Global Coagulation Factor IX Price by Type (2021-2026) & (US$/Unit) Table 43. Global Coagulation Factor IX Price by Type (2027-2032) & (US$/Unit) Table 44. Global Coagulation Factor IX Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Coagulation Factor IX Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Coagulation Factor IX Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Coagulation Factor IX Revenue Market Share by Application (2021-2026) Table 48. Global Coagulation Factor IX Revenue Market Share by Application (2027-2032) Table 49. Global Coagulation Factor IX Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 50. Global Coagulation Factor IX Sales by Application (2021-2026) & (W Units) Table 51. Global Coagulation Factor IX Sales by Application (2027-2032) & (W Units) Table 52. Global Coagulation Factor IX Sales Market Share by Application (2021-2026) Table 53. Global Coagulation Factor IX Sales Market Share by Application (2027-2032) Table 54. Global Coagulation Factor IX Price by Application (2021-2026) & (US$/Unit) Table 55. Global Coagulation Factor IX Price by Application (2027-2032) & (US$/Unit) Table 56. Takeda Company Information Table 57. Takeda Business Overview Table 58. Takeda Coagulation Factor IX Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Takeda Coagulation Factor IX Product Portfolio Table 60. Takeda Recent Development Table 61. Novo Nordisk Company Information Table 62. Novo Nordisk Business Overview Table 63. Novo Nordisk Coagulation Factor IX Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Novo Nordisk Coagulation Factor IX Product Portfolio Table 65. Novo Nordisk Recent Development Table 66. Pfizer Company Information Table 67. Pfizer Business Overview Table 68. Pfizer Coagulation Factor IX Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Pfizer Coagulation Factor IX Product Portfolio Table 70. Pfizer Recent Development Table 71. Baxter Company Information Table 72. Baxter Business Overview Table 73. Baxter Coagulation Factor IX Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Baxter Coagulation Factor IX Product Portfolio Table 75. Baxter Recent Development Table 76. Sanquin Company Information Table 77. Sanquin Business Overview Table 78. Sanquin Coagulation Factor IX Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sanquin Coagulation Factor IX Product Portfolio Table 80. Sanquin Recent Development Table 81. Grifols Company Information Table 82. Grifols Business Overview Table 83. Grifols Coagulation Factor IX Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Grifols Coagulation Factor IX Product Portfolio Table 85. Grifols Recent Development Table 86. CSL Behring Company Information Table 87. CSL Behring Business Overview Table 88. CSL Behring Coagulation Factor IX Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. CSL Behring Coagulation Factor IX Product Portfolio Table 90. CSL Behring Recent Development Table 91. Bioverativ Company Information Table 92. Bioverativ Business Overview Table 93. Bioverativ Coagulation Factor IX Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Bioverativ Coagulation Factor IX Product Portfolio Table 95. Bioverativ Recent Development Table 96. Aptevo Company Information Table 97. Aptevo Business Overview Table 98. Aptevo Coagulation Factor IX Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Aptevo Coagulation Factor IX Product Portfolio Table 100. Aptevo Recent Development Table 101. North America Coagulation Factor IX Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Coagulation Factor IX Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Coagulation Factor IX Sales by Type (2021-2026) & (W Units) Table 104. North America Coagulation Factor IX Sales by Type (2027-2032) & (W Units) Table 105. North America Coagulation Factor IX Sales Price by Type (2021-2026) & (US$/Unit) Table 106. North America Coagulation Factor IX Sales Price by Type (2027-2032) & (US$/Unit) Table 107. North America Coagulation Factor IX Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Coagulation Factor IX Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Coagulation Factor IX Sales by Application (2021-2026) & (W Units) Table 110. North America Coagulation Factor IX Sales by Application (2027-2032) & (W Units) Table 111. North America Coagulation Factor IX Sales Price by Application (2021-2026) & (US$/Unit) Table 112. North America Coagulation Factor IX Sales Price by Application (2027-2032) & (US$/Unit) Table 113. North America Coagulation Factor IX Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Coagulation Factor IX Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 115. North America Coagulation Factor IX Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 116. North America Coagulation Factor IX Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 117. North America Coagulation Factor IX Sales by Country (2021-2026) & (W Units) Table 118. North America Coagulation Factor IX Sales by Country (2027-2032) & (W Units) Table 119. North America Coagulation Factor IX Sales Price by Country (2021-2026) & (US$/Unit) Table 120. North America Coagulation Factor IX Sales Price by Country (2027-2032) & (US$/Unit) Table 121. United States Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 122. Canada Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 123. Europe Coagulation Factor IX Revenue by Type (2021-2026) & (US$ Million) Table 124. Europe Coagulation Factor IX Revenue by Type (2027-2032) & (US$ Million) Table 125. Europe Coagulation Factor IX Sales by Type (2021-2026) & (W Units) Table 126. Europe Coagulation Factor IX Sales by Type (2027-2032) & (W Units) Table 127. Europe Coagulation Factor IX Sales Price by Type (2021-2026) & (US$/Unit) Table 128. Europe Coagulation Factor IX Sales Price by Type (2027-2032) & (US$/Unit) Table 129. Europe Coagulation Factor IX Revenue by Application (2021-2026) & (US$ Million) Table 130. Europe Coagulation Factor IX Revenue by Application (2027-2032) & (US$ Million) Table 131. Europe Coagulation Factor IX Sales by Application (2021-2026) & (W Units) Table 132. Europe Coagulation Factor IX Sales by Application (2027-2032) & (W Units) Table 133. Europe Coagulation Factor IX Sales Price by Application (2021-2026) & (US$/Unit) Table 134. Europe Coagulation Factor IX Sales Price by Application (2027-2032) & (US$/Unit) Table 135. Europe Coagulation Factor IX Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Europe Coagulation Factor IX Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 137. Europe Coagulation Factor IX Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 138. Europe Coagulation Factor IX Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 139. Europe Coagulation Factor IX Sales by Country (2021-2026) & (W Units) Table 140. Europe Coagulation Factor IX Sales by Country (2027-2032) & (W Units) Table 141. Europe Coagulation Factor IX Sales Price by Country (2021-2026) & (US$/Unit) Table 142. Europe Coagulation Factor IX Sales Price by Country (2027-2032) & (US$/Unit) Table 143. Germany Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 144. France Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 145. U.K. Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 146. Italy Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 147. Netherlands Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 148. China Coagulation Factor IX Revenue by Type (2021-2026) & (US$ Million) Table 149. China Coagulation Factor IX Revenue by Type (2027-2032) & (US$ Million) Table 150. China Coagulation Factor IX Sales by Type (2021-2026) & (W Units) Table 151. China Coagulation Factor IX Sales by Type (2027-2032) & (W Units) Table 152. China Coagulation Factor IX Sales Price by Type (2021-2026) & (US$/Unit) Table 153. China Coagulation Factor IX Sales Price by Type (2027-2032) & (US$/Unit) Table 154. China Coagulation Factor IX Revenue by Application (2021-2026) & (US$ Million) Table 155. China Coagulation Factor IX Revenue by Application (2027-2032) & (US$ Million) Table 156. China Coagulation Factor IX Sales by Application (2021-2026) & (W Units) Table 157. China Coagulation Factor IX Sales by Application (2027-2032) & (W Units) Table 158. China Coagulation Factor IX Sales Price by Application (2021-2026) & (US$/Unit) Table 159. China Coagulation Factor IX Sales Price by Application (2027-2032) & (US$/Unit) Table 160. Asia Coagulation Factor IX Revenue by Type (2021-2026) & (US$ Million) Table 161. Asia Coagulation Factor IX Revenue by Type (2027-2032) & (US$ Million) Table 162. Asia Coagulation Factor IX Sales by Type (2021-2026) & (W Units) Table 163. Asia Coagulation Factor IX Sales by Type (2027-2032) & (W Units) Table 164. Asia Coagulation Factor IX Sales Price by Type (2021-2026) & (US$/Unit) Table 165. Asia Coagulation Factor IX Sales Price by Type (2027-2032) & (US$/Unit) Table 166. Asia Coagulation Factor IX Revenue by Application (2021-2026) & (US$ Million) Table 167. Asia Coagulation Factor IX Revenue by Application (2027-2032) & (US$ Million) Table 168. Asia Coagulation Factor IX Sales by Application (2021-2026) & (W Units) Table 169. Asia Coagulation Factor IX Sales by Application (2027-2032) & (W Units) Table 170. Asia Coagulation Factor IX Sales Price by Application (2021-2026) & (US$/Unit) Table 171. Asia Coagulation Factor IX Sales Price by Application (2027-2032) & (US$/Unit) Table 172. Asia Coagulation Factor IX Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. Asia Coagulation Factor IX Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 174. Asia Coagulation Factor IX Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 175. Asia Coagulation Factor IX Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 176. Asia Coagulation Factor IX Sales by Country (2021-2026) & (W Units) Table 177. Asia Coagulation Factor IX Sales by Country (2027-2032) & (W Units) Table 178. Asia Coagulation Factor IX Sales Price by Country (2021-2026) & (US$/Unit) Table 179. Asia Coagulation Factor IX Sales Price by Country (2027-2032) & (US$/Unit) Table 180. Japan Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 181. South Korea Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 182. India Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 183. Australia Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 184. China Taiwan Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 185. Southeast Asia Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 186. SAMEA Coagulation Factor IX Revenue by Type (2021-2026) & (US$ Million) Table 187. SAMEA Coagulation Factor IX Revenue by Type (2027-2032) & (US$ Million) Table 188. SAMEA Coagulation Factor IX Sales by Type (2021-2026) & (W Units) Table 189. SAMEA Coagulation Factor IX Sales by Type (2027-2032) & (W Units) Table 190. SAMEA Coagulation Factor IX Sales Price by Type (2021-2026) & (US$/Unit) Table 191. SAMEA Coagulation Factor IX Sales Price by Type (2027-2032) & (US$/Unit) Table 192. SAMEA Coagulation Factor IX Revenue by Application (2021-2026) & (US$ Million) Table 193. SAMEA Coagulation Factor IX Revenue by Application (2027-2032) & (US$ Million) Table 194. SAMEA Coagulation Factor IX Sales by Application (2021-2026) & (W Units) Table 195. SAMEA Coagulation Factor IX Sales by Application (2027-2032) & (W Units) Table 196. SAMEA Coagulation Factor IX Sales Price by Application (2021-2026) & (US$/Unit) Table 197. SAMEA Coagulation Factor IX Sales Price by Application (2027-2032) & (US$/Unit) Table 198. SAMEA Coagulation Factor IX Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 199. SAMEA Coagulation Factor IX Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 200. SAMEA Coagulation Factor IX Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 201. SAMEA Coagulation Factor IX Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 202. SAMEA Coagulation Factor IX Sales by Country (2021-2026) & (W Units) Table 203. SAMEA Coagulation Factor IX Sales by Country (2027-2032) & (W Units) Table 204. SAMEA Coagulation Factor IX Sales Price by Country (2021-2026) & (US$/Unit) Table 205. SAMEA Coagulation Factor IX Sales Price by Country (2027-2032) & (US$/Unit) Table 206. Brazil Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 207. Argentina Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 208. Chile Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 209. Colombia Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 210. Peru Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 211. Saudi Arabia Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 212. Israel Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 213. UAE Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 214. Turkey Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 215. Iran Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 216. Egypt Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Table 217. Key Raw Materials Table 218. Raw Materials Key Suppliers Table 219. Coagulation Factor IX Distributors List Table 220. Coagulation Factor IX Customers List Table 221. Research Programs/Design for This Report Table 222. Authors List of This Report Table 223. Secondary Sources Table 224. Primary Sources List of Figures Figure 1. Coagulation Factor IX Image Figure 2. Global Coagulation Factor IX Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coagulation Factor IX Market Size Share 2021 VS 2025 VS 2032 Figure 4. Coagulation Factor IX (Plasma Derived) Image Figure 5. Coagulation Factor IX (Recombinant) Image Figure 6. Global Coagulation Factor IX Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Coagulation Factor IX Market Size Share 2021 VS 2025 VS 2032 Figure 8. Adult Image Figure 9. Kids Image Figure 10. Global Coagulation Factor IX Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Figure 12. Global Coagulation Factor IX Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Coagulation Factor IX Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Coagulation Factor IX Revenue Market Share by Region (2021-2032) Figure 15. Global Coagulation Factor IX Sales (2021-2032) & (W Units) Figure 16. Global Coagulation Factor IX Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 17. Global Coagulation Factor IX Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Coagulation Factor IX Sales YoY (2021-2032) & (W Units) Figure 19. Europe Coagulation Factor IX Sales YoY (2021-2032) & (W Units) Figure 20. China Coagulation Factor IX Sales YoY (2021-2032) & (W Units) Figure 21. Asia (Excluding China) Coagulation Factor IX Sales YoY (2021-2032) & (W Units) Figure 22. South America, Middle East and Africa Coagulation Factor IX Sales YoY (2021-2032) & (W Units) Figure 23. Global Coagulation Factor IX Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Coagulation Factor IX Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Coagulation Factor IX Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Coagulation Factor IX Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Coagulation Factor IX Revenue Market Share by Type (2021-2032) Figure 29. Global Coagulation Factor IX Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 30. Global Coagulation Factor IX Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Coagulation Factor IX Sales Market Share by Type (2021-2032) Figure 32. Global Coagulation Factor IX Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Coagulation Factor IX Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Coagulation Factor IX Revenue Market Share by Application (2021-2032) Figure 35. Global Coagulation Factor IX Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 36. Global Coagulation Factor IX Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Coagulation Factor IX Sales Market Share by Application (2021-2032) Figure 38. North America Coagulation Factor IX Revenue Share by Type (2021-2032) Figure 39. North America Coagulation Factor IX Sales Share by Type (2021-2032) Figure 40. North America Coagulation Factor IX Revenue Share by Application (2021-2032) Figure 41. North America Coagulation Factor IX Sales Share by Application (2021-2032) Figure 42. North America Coagulation Factor IX Revenue Share by Country (2021-2032) Figure 43. North America Coagulation Factor IX Sales Share by Country (2021-2032) Figure 44. Europe Coagulation Factor IX Revenue Share by Type (2021-2032) Figure 45. Europe Coagulation Factor IX Sales Share by Type (2021-2032) Figure 46. Europe Coagulation Factor IX Revenue Share by Application (2021-2032) Figure 47. Europe Coagulation Factor IX Sales Share by Application (2021-2032) Figure 48. Europe Coagulation Factor IX Revenue Share by Country (2021-2032) Figure 49. Europe Coagulation Factor IX Sales Share by Country (2021-2032) Figure 50. China Coagulation Factor IX Revenue Share by Type (2021-2032) Figure 51. China Coagulation Factor IX Sales Share by Type (2021-2032) Figure 52. China Coagulation Factor IX Revenue Share by Application (2021-2032) Figure 53. China Coagulation Factor IX Sales Share by Application (2021-2032) Figure 54. Asia Coagulation Factor IX Revenue Share by Type (2021-2032) Figure 55. Asia Coagulation Factor IX Sales Share by Type (2021-2032) Figure 56. Asia Coagulation Factor IX Revenue Share by Application (2021-2032) Figure 57. Asia Coagulation Factor IX Sales Share by Application (2021-2032) Figure 58. Asia Coagulation Factor IX Revenue Share by Country (2021-2032) Figure 59. Asia Coagulation Factor IX Sales Share by Country (2021-2032) Figure 60. SAMEA Coagulation Factor IX Revenue Share by Type (2021-2032) Figure 61. SAMEA Coagulation Factor IX Sales Share by Type (2021-2032) Figure 62. SAMEA Coagulation Factor IX Revenue Share by Application (2021-2032) Figure 63. SAMEA Coagulation Factor IX Sales Share by Application (2021-2032) Figure 64. SAMEA Coagulation Factor IX Revenue Share by Country (2021-2032) Figure 65. SAMEA Coagulation Factor IX Sales Share by Country (2021-2032) Figure 66. Coagulation Factor IX Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Coagulation Factor IX Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Coagulation Factor IX (Plasma Derived)
  • Coagulation Factor IX (Recombinant)
Applications
  • Adult
  • Kids
Companies covered
  • Takeda
  • Novo Nordisk
  • Pfizer
  • Baxter
  • Sanquin
  • Grifols
  • CSL Behring
  • Bioverativ
  • Aptevo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Coagulation Factor IX Market by Type
  3. 1.2.1 Global Coagulation Factor IX Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Coagulation Factor IX (Plasma Derived)
  5. 1.2.3 Coagulation Factor IX (Recombinant)
  6. 1.3 Coagulation Factor IX Market by Application
  7. 1.3.1 Global Coagulation Factor IX Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Adult
  9. 1.3.3 Kids
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Coagulation Factor IX Market Dynamics
  1. 2.1 Coagulation Factor IX Industry Trends
  2. 2.2 Coagulation Factor IX Industry Drivers
  3. 2.3 Coagulation Factor IX Industry Opportunities and Challenges
  4. 2.4 Coagulation Factor IX Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Coagulation Factor IX Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Coagulation Factor IX Revenue by Region
  3. 3.2.1 Global Coagulation Factor IX Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Coagulation Factor IX Revenue by Region (2021-2026)
  5. 3.2.3 Global Coagulation Factor IX Revenue by Region (2027-2032)
  6. 3.2.4 Global Coagulation Factor IX Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Coagulation Factor IX Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Coagulation Factor IX Sales by Region
  9. 3.4.1 Global Coagulation Factor IX Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Coagulation Factor IX Sales by Region (2021-2026)
  11. 3.4.3 Global Coagulation Factor IX Sales by Region (2027-2032)
  12. 3.4.4 Global Coagulation Factor IX Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Coagulation Factor IX Revenue by Manufacturers
  2. 4.1.1 Global Coagulation Factor IX Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Coagulation Factor IX Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Coagulation Factor IX Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Coagulation Factor IX Sales by Manufacturers
  6. 4.2.1 Global Coagulation Factor IX Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Coagulation Factor IX Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Coagulation Factor IX Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Coagulation Factor IX Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Coagulation Factor IX Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Coagulation Factor IX Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Coagulation Factor IX Manufacturers, Product Type & Application
  13. 4.7 Global Coagulation Factor IX Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Coagulation Factor IX Market CR5 and HHI
  16. 4.8.2 2025 Coagulation Factor IX Tier 1, Tier 2, and Tier 3
5 Coagulation Factor IX Market by Type
  1. 5.1 Global Coagulation Factor IX Revenue by Type
  2. 5.1.1 Global Coagulation Factor IX Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Coagulation Factor IX Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Coagulation Factor IX Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Coagulation Factor IX Sales by Type
  6. 5.2.1 Global Coagulation Factor IX Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Coagulation Factor IX Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Coagulation Factor IX Sales Market Share by Type (2021-2032)
  9. 5.3 Global Coagulation Factor IX Price by Type
6 Coagulation Factor IX Market by Application
  1. 6.1 Global Coagulation Factor IX Revenue by Application
  2. 6.1.1 Global Coagulation Factor IX Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Coagulation Factor IX Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Coagulation Factor IX Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Coagulation Factor IX Sales by Application
  6. 6.2.1 Global Coagulation Factor IX Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Coagulation Factor IX Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Coagulation Factor IX Sales Market Share by Application (2021-2032)
  9. 6.3 Global Coagulation Factor IX Price by Application
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Coagulation Factor IX Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Novo Nordisk
  8. 7.2.1 Novo Nordisk Company Information
  9. 7.2.2 Novo Nordisk Business Overview
  10. 7.2.3 Novo Nordisk Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novo Nordisk Coagulation Factor IX Product Portfolio
  12. 7.2.5 Novo Nordisk Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Coagulation Factor IX Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 Baxter
  20. 7.4.1 Baxter Company Information
  21. 7.4.2 Baxter Business Overview
  22. 7.4.3 Baxter Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Baxter Coagulation Factor IX Product Portfolio
  24. 7.4.5 Baxter Recent Developments
  25. 7.5 Sanquin
  26. 7.5.1 Sanquin Company Information
  27. 7.5.2 Sanquin Business Overview
  28. 7.5.3 Sanquin Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sanquin Coagulation Factor IX Product Portfolio
  30. 7.5.5 Sanquin Recent Developments
  31. 7.6 Grifols
  32. 7.6.1 Grifols Company Information
  33. 7.6.2 Grifols Business Overview
  34. 7.6.3 Grifols Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Grifols Coagulation Factor IX Product Portfolio
  36. 7.6.5 Grifols Recent Developments
  37. 7.7 CSL Behring
  38. 7.7.1 CSL Behring Company Information
  39. 7.7.2 CSL Behring Business Overview
  40. 7.7.3 CSL Behring Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 CSL Behring Coagulation Factor IX Product Portfolio
  42. 7.7.5 CSL Behring Recent Developments
  43. 7.8 Bioverativ
  44. 7.8.1 Bioverativ Company Information
  45. 7.8.2 Bioverativ Business Overview
  46. 7.8.3 Bioverativ Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Bioverativ Coagulation Factor IX Product Portfolio
  48. 7.8.5 Bioverativ Recent Developments
  49. 7.9 Aptevo
  50. 7.9.1 Aptevo Company Information
  51. 7.9.2 Aptevo Business Overview
  52. 7.9.3 Aptevo Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Aptevo Coagulation Factor IX Product Portfolio
  54. 7.9.5 Aptevo Recent Developments
8 North America
  1. 8.1 North America Coagulation Factor IX Market Size by Type
  2. 8.1.1 North America Coagulation Factor IX Revenue by Type (2021-2032)
  3. 8.1.2 North America Coagulation Factor IX Sales by Type (2021-2032)
  4. 8.1.3 North America Coagulation Factor IX Price by Type (2021-2032)
  5. 8.2 North America Coagulation Factor IX Market Size by Application
  6. 8.2.1 North America Coagulation Factor IX Revenue by Application (2021-2032)
  7. 8.2.2 North America Coagulation Factor IX Sales by Application (2021-2032)
  8. 8.2.3 North America Coagulation Factor IX Price by Application (2021-2032)
  9. 8.3 North America Coagulation Factor IX Market Size by Country
  10. 8.3.1 North America Coagulation Factor IX Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Coagulation Factor IX Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Coagulation Factor IX Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Coagulation Factor IX Market Size by Type
  2. 9.1.1 Europe Coagulation Factor IX Revenue by Type (2021-2032)
  3. 9.1.2 Europe Coagulation Factor IX Sales by Type (2021-2032)
  4. 9.1.3 Europe Coagulation Factor IX Price by Type (2021-2032)
  5. 9.2 Europe Coagulation Factor IX Market Size by Application
  6. 9.2.1 Europe Coagulation Factor IX Revenue by Application (2021-2032)
  7. 9.2.2 Europe Coagulation Factor IX Sales by Application (2021-2032)
  8. 9.2.3 Europe Coagulation Factor IX Price by Application (2021-2032)
  9. 9.3 Europe Coagulation Factor IX Market Size by Country
  10. 9.3.1 Europe Coagulation Factor IX Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Coagulation Factor IX Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Coagulation Factor IX Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Coagulation Factor IX Market Size by Type
  2. 10.1.1 China Coagulation Factor IX Revenue by Type (2021-2032)
  3. 10.1.2 China Coagulation Factor IX Sales by Type (2021-2032)
  4. 10.1.3 China Coagulation Factor IX Price by Type (2021-2032)
  5. 10.2 China Coagulation Factor IX Market Size by Application
  6. 10.2.1 China Coagulation Factor IX Revenue by Application (2021-2032)
  7. 10.2.2 China Coagulation Factor IX Sales by Application (2021-2032)
  8. 10.2.3 China Coagulation Factor IX Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Coagulation Factor IX Market Size by Type
  2. 11.1.1 Asia Coagulation Factor IX Revenue by Type (2021-2032)
  3. 11.1.2 Asia Coagulation Factor IX Sales by Type (2021-2032)
  4. 11.1.3 Asia Coagulation Factor IX Price by Type (2021-2032)
  5. 11.2 Asia Coagulation Factor IX Market Size by Application
  6. 11.2.1 Asia Coagulation Factor IX Revenue by Application (2021-2032)
  7. 11.2.2 Asia Coagulation Factor IX Sales by Application (2021-2032)
  8. 11.2.3 Asia Coagulation Factor IX Price by Application (2021-2032)
  9. 11.3 Asia Coagulation Factor IX Market Size by Country
  10. 11.3.1 Asia Coagulation Factor IX Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Coagulation Factor IX Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Coagulation Factor IX Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Coagulation Factor IX Market Size by Type
  2. 12.1.1 SAMEA Coagulation Factor IX Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Coagulation Factor IX Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Coagulation Factor IX Price by Type (2021-2032)
  5. 12.2 SAMEA Coagulation Factor IX Market Size by Application
  6. 12.2.1 SAMEA Coagulation Factor IX Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Coagulation Factor IX Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Coagulation Factor IX Price by Application (2021-2032)
  9. 12.3 SAMEA Coagulation Factor IX Market Size by Country
  10. 12.3.1 SAMEA Coagulation Factor IX Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Coagulation Factor IX Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Coagulation Factor IX Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Coagulation Factor IX Value Chain Analysis
  2. 13.1.1 Coagulation Factor IX Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Coagulation Factor IX Production Mode & Process
  6. 13.2 Coagulation Factor IX Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Coagulation Factor IX Distributors
  9. 13.2.3 Coagulation Factor IX Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst